These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22907527)
1. Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in mice. Synold TW; Xi B; Wu J; Yen Y; Li BC; Yang F; Phillips JW; Nickols NG; Dervan PB Cancer Chemother Pharmacol; 2012 Oct; 70(4):617-25. PubMed ID: 22907527 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of pyrrole-imidazole polyamides after intravenous administration in rat. Fukasawa A; Aoyama T; Nagashima T; Fukuda N; Ueno T; Sugiyama H; Nagase H; Matsumoto Y Biopharm Drug Dispos; 2009 Mar; 30(2):81-9. PubMed ID: 19226654 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Py-Im polyamides depend on architecture: cyclic versus linear. Raskatov JA; Hargrove AE; So AY; Dervan PB J Am Chem Soc; 2012 May; 134(18):7995-9. PubMed ID: 22509786 [TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography. Harki DA; Satyamurthy N; Stout DB; Phelps ME; Dervan PB Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13039-44. PubMed ID: 18753620 [TBL] [Abstract][Full Text] [Related]
5. Cyclic pyrrole-imidazole polyamides targeted to the androgen response element. Chenoweth DM; Harki DA; Phillips JW; Dose C; Dervan PB J Am Chem Soc; 2009 May; 131(20):7182-8. PubMed ID: 19413319 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic modeling and prediction of plasma pyrrole-imidazole polyamide concentration in rats using simultaneous urinary and biliary excretion data. Nagashima T; Aoyama T; Yokoe T; Fukasawa A; Fukuda N; Ueno T; Sugiyama H; Nagase H; Matsumoto Y Biol Pharm Bull; 2009 May; 32(5):921-7. PubMed ID: 19420765 [TBL] [Abstract][Full Text] [Related]
7. Binding of hairpin pyrrole and imidazole polyamides to DNA: relationship between torsion angle and association rate constants. Han YW; Matsumoto T; Yokota H; Kashiwazaki G; Morinaga H; Hashiya K; Bando T; Harada Y; Sugiyama H Nucleic Acids Res; 2012 Dec; 40(22):11510-7. PubMed ID: 23042247 [TBL] [Abstract][Full Text] [Related]
8. Orientation preferences of hairpin pyrrole-imidazole polyamides toward Sato S; Asamitsu S; Bando T; Sugiyama H Bioorg Med Chem; 2019 Jun; 27(11):2167-2171. PubMed ID: 31000407 [TBL] [Abstract][Full Text] [Related]
9. Modifications at the C-terminus to improve pyrrole-imidazole polyamide activity in cell culture. Jacobs CS; Dervan PB J Med Chem; 2009 Dec; 52(23):7380-8. PubMed ID: 19572551 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides. Liu B; Kodadek T J Med Chem; 2009 Aug; 52(15):4604-12. PubMed ID: 19610652 [TBL] [Abstract][Full Text] [Related]
11. Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted. Raskatov JA; Szablowski JO; Dervan PB J Med Chem; 2014 Oct; 57(20):8471-6. PubMed ID: 25238175 [TBL] [Abstract][Full Text] [Related]
13. Animal toxicity of hairpin pyrrole-imidazole polyamides varies with the turn unit. Yang F; Nickols NG; Li BC; Szablowski JO; Hamilton SR; Meier JL; Wang CM; Dervan PB J Med Chem; 2013 Sep; 56(18):7449-57. PubMed ID: 24015881 [TBL] [Abstract][Full Text] [Related]
14. A C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor. Raskatov JA; Puckett JW; Dervan PB Bioorg Med Chem; 2014 Aug; 22(16):4371-5. PubMed ID: 24780272 [TBL] [Abstract][Full Text] [Related]
15. Sequence-specific DNA binding Pyrrole-imidazole polyamides and their applications. Kawamoto Y; Bando T; Sugiyama H Bioorg Med Chem; 2018 May; 26(8):1393-1411. PubMed ID: 29439914 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of sequence-specific DNA-alkylating pyrrole-imidazole polyamides. Bando T; Sugiyama H Acc Chem Res; 2006 Dec; 39(12):935-44. PubMed ID: 17176032 [TBL] [Abstract][Full Text] [Related]
17. Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides. Dickinson LA; Trauger JW; Baird EE; Ghazal P; Dervan PB; Gottesfeld JM Biochemistry; 1999 Aug; 38(33):10801-7. PubMed ID: 10451376 [TBL] [Abstract][Full Text] [Related]
18. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433 [TBL] [Abstract][Full Text] [Related]
19. Sequence-specific DNA binding by long hairpin pyrrole-imidazole polyamides containing an 8-amino-3,6-dioxaoctanoic acid unit. Sawatani Y; Kashiwazaki G; Chandran A; Asamitsu S; Guo C; Sato S; Hashiya K; Bando T; Sugiyama H Bioorg Med Chem; 2016 Aug; 24(16):3603-11. PubMed ID: 27301681 [TBL] [Abstract][Full Text] [Related]
20. Cell permeability of Py-Im-polyamide-fluorescein conjugates: Influence of molecular size and Py/Im content. Nishijima S; Shinohara K; Bando T; Minoshima M; Kashiwazaki G; Sugiyama H Bioorg Med Chem; 2010 Jan; 18(2):978-83. PubMed ID: 20022508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]